Shinobi Therapeutics
Healthcare & Life Sciences
Recent Finacing
Series A
Recent Raise
$51M
Shinobi Therapeutics is a biotech company developing off-the-shelf, immune-evasive, induced pluripotent stem cell (iPSC)-derived cell therapies for GPC3+ solid tumor cancers.
Focus Areas
Biotechnology
iPS-T cell therapy
Hypoimmune platform
Solid tumor cancers
Off-the-shelf cell therapies
Clinical trials
Investors
